Study Information

What’s involved?

  • 6 days & nights inpatient stay
  • 6 follow up visits

Participants are reimbursed for their time and this clinical trial has been approved by an independent ethics committee.

About the study

This study is looking at developing a treatment medication for obesity management and Type-2 diabetes. This new drug mimics the actions of a hormone called GLP-1 (glucagon-like peptide 1) that is naturally produced in the body. GLP-1 is produced in the intestine and brain and primarily serves to control blood sugar levels, appetite and stomach emptying. The new drug is very similar in structure to normal human GLP-1 and so may have similar effects in your body. Participants in this
study will receive a single dose of this medication and then return to the centre for follow up appointments.

How do I find out more?

If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at reply@clinicalstudies.com.au quoting “Body Weight Study”.

If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!

  • 6
    Nights Inpatient Stay
  • 6
    Outpatient Visits

Minimum Eligibility Requirements:

  • Healthy males or females
  • BMI 20 - 35/m2
  • Aged 18 – 55 years old
  • No significant medical history
  • Social smokers ok (no more than 10 per week)
Top